Catalyst Wire Dossier Catalyst Wire Dossier

ORA102

· Ora Bio Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORA102, covering 2009-06-09 to 2009-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1, Phase 2]

See pricing